Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Gains from Sales and Divestitures (2016 - 2018)

Vanda Pharmaceuticals' Gains from Sales and Divestitures history spans 8 years, with the latest figure at $475367.0 for Q1 2018.

  • On a quarterly basis, Gains from Sales and Divestitures rose 36.79% to $475367.0 in Q1 2018 year-over-year; TTM through Mar 2018 was $475367.0, a 36.79% increase, with the full-year FY2017 number at $362313.0, up 25.95% from a year prior.
  • Gains from Sales and Divestitures hit $475367.0 in Q1 2018 for Vanda Pharmaceuticals, up from $362313.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for VNDA hit a ceiling of $475367.0 in Q1 2018 and a floor of $209562.0 in Q1 2014.
  • Historically, Gains from Sales and Divestitures has averaged $282623.5 across 5 years, with a median of $287666.0 in 2016.
  • The widest YoY moves for Gains from Sales and Divestitures: up 37.48% in 2014, down 4.16% in 2014.
  • Tracing VNDA's Gains from Sales and Divestitures over 5 years: stood at $209562.0 in 2014, then rose by 10.27% to $231093.0 in 2015, then increased by 24.48% to $287666.0 in 2016, then increased by 25.95% to $362313.0 in 2017, then surged by 31.2% to $475367.0 in 2018.
  • Business Quant data shows Gains from Sales and Divestitures for VNDA at $475367.0 in Q1 2018, $362313.0 in Q4 2017, and $356127.0 in Q3 2017.